Invega Sustenna 75mg Injection
Marketer
Janssen Pharmaceuticals
Salt Composition
Paliperidone (75mg)
Overview Invega Sustenna 75mg Injection
Palmitate paliperidone 75mg injection treats schizophrenia (a disorder causing hallucinations, delusions, and impaired thinking/behavior) and mania. Administered by a healthcare provider, this injection should be taken consistently at the same time daily for optimal blood levels. Sudden discontinuation is unsafe and may exacerbate symptoms; immediately cease use if Neuroleptic Malignant Syndrome (NMS) occurs (fever, muscle stiffness, altered mental state). Common side effects include injection site reactions (pain, swelling, redness), involuntary eye movements (nystagmus), tremor, dizziness, and drowsiness. Avoid driving or activities requiring alertness until effects are known. Increased diabetes risk necessitates regular glucose monitoring. Report mood/behavioral changes, new or worsening depression, or suicidal thoughts to your doctor. A patient support/assistance program exists in India, managed by Tata 1mg; consult your physician or call (1800-102-1618) for details.
Uses of Invega Sustenna 75mg Injection
Psychotic disorders involving psychosis and mood elevation
Major Benefits of Invega Sustenna 75mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Invega Sustenna 75mg Injection:
- Abnormal involuntary movements
- Dizziness
- Injection site reactions (pain, swelling, redness)
- Nystagmus (involuntary eye movement)
- Sleepiness
- Tremors
How to use Invega Sustenna 75mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Invega Sustenna 75mg Injection works:
Xeplion 75mg, an atypical antipsychotic injection, modifies neurotransmitter levels (dopamine and serotonin), thereby enhancing cognitive function, emotional stability, and behavioral control.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Invega Sustenna 75mg Injection is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Using Invega Sustenna 75mg Injection during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to a developing fetus. A physician will assess the benefits against potential dangers before prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Using Invega Sustenna 75mg Injection while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Patients receiving Invega Sustenna 75mg injections may experience drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are present.
KidneyCAUTION
Patients with kidney impairment should use Invega Sustenna 75mg Injection cautiously, potentially requiring dose modification. Physician consultation is advised. Invega Sustenna 75mg Injection is contraindicated in individuals with end-stage renal disease.
LiverCAUTION
Patients with severe hepatic impairment should use Invega Sustenna 75mg Injection cautiously, potentially requiring dosage modification. Advice from a physician is recommended. Data regarding Invega Sustenna 75mg Injection use in such patients is limited; however, dosage alterations are not advised for those with mild to moderate liver disease.
What if you forget to take Invega Sustenna 75mg Injection :
NA
Facts to Know About Invega Sustenna 75mg Injection
| Label | Value |
|---|---|
| Chemical Category | Benzisoxazole compound |
| Developing Habits | No. |
| Type of Therapy | Neuroscience Central Nervous System |
| Action Class | Novel Antipsychotics |
3,018 People bought this recently